SCHEMBL7779570

SCHEMBL7779570

CN(C)CCn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccccc2)c1C(F)(F)F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.62
PTGS1 P23219 5/20 0.62
PDPK1 O15530 1/20 0.44
CA12 O43570 1/20 0.43
MT-CO2 P00403 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
LMNA P02545 1/20 0.43
CA3 P07451 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
ADRA2B P18089 1/20 0.43
CA4 P22748 1/20 0.43
CA6 P23280 1/20 0.43
SLC6A2 P23975 1/20 0.43
PDE4A P27815 1/20 0.43
ADORA1 P30542 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777885 0.92 PTGS2 (0.62) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7777915 0.92 PTGS2 (0.75) PTGS2PTGS1CA12CA1CA2
SCHEMBL7780881 0.91 PTGS2 (0.61) PTGS2PTGS1PDPK1CA12CA1
SCHEMBL7778122 0.91 PTGS2 (0.61) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7779473 0.91 PTGS2 (0.61) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7777326 0.91 PTGS2 (0.68) PTGS2PTGS1
SCHEMBL7780599 0.89 PTGS2 (0.59) PTGS2PTGS1CA12CA1CA2
SCHEMBL7779368 0.89 PTGS2 (0.59) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7777719 0.88 PTGS2 (0.53) PTGS2PTGS1PDPK1CA12MT-CO2
SCHEMBL7777973 0.86 PTGS2 (0.83) PTGS2PTGS1PDPK1CA12MT-CO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed